Kardio-metabolische Charakterisierung von Patienten mit Typ 2 ...
Kardio-metabolische Charakterisierung von Patienten mit Typ 2 ...
Kardio-metabolische Charakterisierung von Patienten mit Typ 2 ...
Erfolgreiche ePaper selbst erstellen
Machen Sie aus Ihren PDF Publikationen ein blätterbares Flipbook mit unserer einzigartigen Google optimierten e-Paper Software.
24. Van de Laar FA, Lucassen PL, Akkermans RP, Van de Lisdonk EH, De Grauw WJ:<br />
Alpha-glucosidase inhibitors for people with impaired glucose tolerance or impaired<br />
fasting blood glucose. Cochrane Database Syst Rev 2006; 18: CD005061.<br />
25. Petrella RJ, Lattanzio CN, Demeray A, Varallo V, Blore R: Can adoption of regular<br />
exercise later in life prevent metabolic risk for cardiovascular disease? Diabetes Care<br />
2005; 28: 694-701.<br />
26. Lindstrom J, Ilanne-Parikka P, Peltonen M, Aunola S, Eriksson JG, Hemio K,<br />
Hamalainen H, Harkonen P, Keinanen-Kiukaanniemi S, Laakso M, Louheranta A,<br />
Mannelin M, Paturi M, Sundvall J, Valle TT, Uusitupa M, Tuomilehto J: Sustained<br />
reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the<br />
Finnish Diabetes Prevention Study. Lancet 2006; 368: 1673-1679.<br />
27. Tuomilehto J, Lindstrom J, Eriksson JG, Valle TT, Hamalainen H, Ilanne-Parikka P,<br />
Keinanen-Kiukaanniemi S, Laakso M, Louheranta A, Rastas M, Salminen V, Uusitupa<br />
M: Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with<br />
impaired glucose tolerance. N Engl J Med 2001; 344: 1343-1350.<br />
28. Pan XR, Li GW, Hu YH, Wang JX, Yang WY, An ZX, Hu ZX, Lin J, Xiao JZ, Cao HB,<br />
Liu PA, Jiang XG, Jiang YY, Wang JP, Zheng H, Zhang H, Bennett PH, Howard BV:<br />
Effects of diet and exercise in preventing NIDDM in people with impaired glucose<br />
tolerance. The Da Qing IGT and Diabetes Study. Diabetes Care 1997; 20: 537-544.<br />
29. Jonker JT, De Laet C, Franco OH, Peeters A, Mackenbach J, Nusselder WJ: Physical<br />
activity and life expectancy with and without diabetes: life table analysis of the<br />
Framingham Heart Study. Diabetes Care 2006; 29: 38-43.<br />
30. Gaede P, Lund-Andersen H, Parving HH, Pedersen O: Effect of a multifactorial<br />
intervention on mortality in type 2 diabetes. N Engl J Med 2008; 358: 580-591.<br />
31. Hu FB, Stampfer MJ, Haffner SM, Solomon CG, Willett WC, Manson JE: Elevated<br />
risk of cardiovascular disease prior to clinical diagnosis of type 2 diabetes. Diabetes<br />
Care 2002; 25: 1129-1134.<br />
32. Hanley AJG, Williams K, Stern MP, Haffner SM: Homeostasis model assessment of<br />
insulin resistance in relation to the incidence of cardiovascular disease: the San<br />
Antonio Heart Study. Diabetes Care 2002; 25: 1177-1184.<br />
42